Company intelligence / Profile preview

Tesu Health

Cambridge, United Kingdomdemocracy.cambridgeshirepeterborough-ca.gov.uk ↗

Ownership: Private
Development stage: Other

Overview

Tesu Health develops evidence-based, clinically validated digital therapeutics targeting chronic noncommunicable diseases. Its flagship product PreDiaWell® has achieved high scores in independent health app assessments. The company focuses on software interventions that drive behavioral change to reverse or halt disease progression. Clinical results are positive enough to secure regulatory certifications and international expansion support.[1][4]

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Digital therapeutic (software-based intervention)Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Cambridge Life Sciences Market Access Programme (UK government-supported initiative)Cube Incubation (incubator/investor)

Beyond the preview

Go deeper on Tesu Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tesu Health.

Explore the full profile